Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Almirall, S.A.”

71 pharma patents match "Almirall, S.A." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 71
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 71 pharmaceutical patents matching "Almirall, S.A." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

71 results for “Almirall, S.A.” · 30,257 patents in full index Clear search

  1. US 7964615

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor

    Almirall, S.A. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  2. US 7960383

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  3. US 7906530

    1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

    Laboratories Almirall, S.A. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted
  4. US 7893087

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted
  5. US 7879874

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted
  6. US 7855202

    Imidazopyridine derivatives as A2B adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  7. US 7790728

    Pyrazine derivatives useful as adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted
  8. US 7776879

    Quinuclidine carbamate derivatives and their use as M3 antagonists

    Almirall, S.A. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted
  9. US 7750023

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted
  10. US 7718670

    Quinuclidine amide derivatives

    Laboratories Almirall, S.A. · Granted May 18, 2010 · Expires May 13, 2030

    granted
  11. US 7662814

    4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors

    Laboratories Almirall, S.A. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted
  12. US 7622480

    Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents

    Laboratories Almirall, S.A. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  13. US 7582676

    2-phenylpyran-4-one derivatives as selective COX-2 inhibitors

    Laboratories Almirall, S.A. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  14. US 7560471

    Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents

    Laboratories Almirall, S.A. · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted
  15. US 7557212

    Tricyclic derivatives as LTD4 antagonists

    Laboratories Almirall, S.A. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted
  16. US 7511038

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  17. US 7504398

    Substituted-4-(pyrrolo pyrimidin-6-yl)benzenesulphonamide derivatives

    Laboratories Almirall, S.A. · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted
  18. US 7491722

    Pyridazin-3(2H)-one derivatives

    Laboratories Almirall, S.A. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted
  19. US 7488735

    Quinuclidine amide derivatives

    Laboratories Almirall, S.A. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  20. US 7459453

    Pyridazin-3(2H)-one derivatives as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted
  21. US 7435742

    Quinuclidine derivatives and pharmaceutical compositions containing the same

    Laboratories Almirall, S.A. · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  22. US 7358260

    Quinuclidine derivatives and medicinal compositions containing the same

    Laboratories Almirall, S.A. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted
  23. US 7253171

    Urea derivatives as integrin α4 antagonists

    Laboratories Almirall, S.A. · Granted Aug 7, 2007 · Expires Aug 2, 2027

    granted